Safety and Efficacy of Selumetinib in Pediatric and Adult Patients with Neurofibromatosis Type 1 and Plexiform Neurofibroma

This open-label, phase II trial enrolled 90 pediatric or adult NF1 patients with inoperable, symptomatic, or potentially morbid, measurable plexiform neurofibroma.